Medical Spa on top of a crack in the earth.

NEWS

Why Med Spas Are Becoming a Growing Source of MPL Risk

November 10, 2025

Med-spas and office-based aesthetic clinics have become one of the fastest-growing segments of consumer healthcare. Services that were once the exclusive domain of dermatologists and plastic surgeons are now offered in boutique retail environments, hybrid wellness centers, and standalone injector practices. The appeal is clear: high demand, high margins, and an audience eager for minimally invasive cosmetic treatments. Yet behind the glossy marketing and spa-like atmosphere, these businesses operate as medical practices. That simple fact places them squarely within the realm of medical professional liability, even when many operators do not fully appreciate the risks involved.

Part of the challenge is that the regulatory framework governing med-spas has not kept pace with their growth. Each state approaches aesthetics differently, and rules regarding supervision, delegation, and who may legally perform injections vary widely. In some jurisdictions, physicians must supervise cosmetic procedures directly; in others, oversight can be remote or delegated to advanced practice providers. This fragmented environment allows significant variation in how treatments are delivered. It also leaves room for misunderstanding about what constitutes appropriate clinical oversight. Enforcement actions reported by legal observers show that lapses in supervision remain one of the most common triggers for regulatory scrutiny.

‍

Clinical Complications That Challenge the “Low-Risk” Narrative

The clinical risks themselves are not theoretical. Despite the perception that cosmetic procedures are “low risk,” industry case reports show recurring injuries: laser burns, filler-related vascular complications, infections following microneedling or threads, and nerve damage arising from injections performed without adequate anatomical knowledge. Many of these incidents originate in settings that blend medical care with retail culture, where rapid-fire scheduling, minimal pre-procedure assessment, or an overreliance on scripted consultations can allow genuine clinical concerns to go unaddressed. When complications arise, plaintiffs often argue that expectations were poorly managed, risks were not properly explained, or follow-up care was inconsistent or absent.

One of the most persistent areas of vulnerability involves informed consent and patient communication. Aesthetics is an expectations-driven specialty; patients often arrive with strong visual goals or social-media-influenced expectations. When procedures do not produce the desired outcome, even if performed correctly, the absence of detailed, well-documented conversations about limitations and risks becomes a focal point in disputes. Consent processes that work for medical necessity may be inadequate for elective cosmetic care, where dissatisfaction itself can morph into a perceived injury, especially when the documentation trail is thin.

Our team is your team.

Get a quote

Insurance Misunderstandings That Leave Clinics Exposed

Another complication is that many med-spas misunderstand the insurance protections they actually have. It is common for non-physician injectors to assume they are covered under a medical director’s policy, even though most policies extend only to the named insured’s direct acts—not to independent injectors or spa employees. Similarly, facilities sometimes mistake general liability coverage for professional liability, leaving gaps that become apparent only after a claim is made. These misunderstandings create a perfect storm: growing demand, inconsistent oversight, and a widespread belief that existing policies are more comprehensive than they really are.

For MPL agents, this environment represents both a challenge and an opportunity. As med-spas expand, agents who understand the medical, regulatory, and operational nuances of this sector can provide substantial value by helping clients identify their true exposures. Aesthetic practices often grow quickly and informally, adding services, new injectors, and devices without revisiting their insurance structures. Agents who raise thoughtful questions about supervision, credentialing, documentation, and follow-up care become trusted advisors rather than transactional brokers. In a market where the gap between perceived and actual risk remains wide, informed guidance can make the difference between a clinic that thrives and one that becomes vulnerable to preventable, high-severity claims.